Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076373

Expand all

CARVEDILOL (CARVEDILOL)
3.125MG
Marketing Status: Prescription

Active Ingredient: CARVEDILOL
Proprietary Name: CARVEDILOL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076373
Product Number: 001
Approval Date: Sep 5, 2007
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CARVEDILOL (CARVEDILOL)
6.25MG
Marketing Status: Prescription

Active Ingredient: CARVEDILOL
Proprietary Name: CARVEDILOL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076373
Product Number: 002
Approval Date: Sep 5, 2007
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CARVEDILOL (CARVEDILOL)
12.5MG
Marketing Status: Prescription

Active Ingredient: CARVEDILOL
Proprietary Name: CARVEDILOL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076373
Product Number: 003
Approval Date: Sep 5, 2007
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CARVEDILOL (CARVEDILOL)
25MG
Marketing Status: Prescription

Active Ingredient: CARVEDILOL
Proprietary Name: CARVEDILOL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076373
Product Number: 004
Approval Date: Sep 5, 2007
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information